Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-20-019519
Filing Date
2020-04-29
Accepted
2020-04-29 11:55:02
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ttoo-10ka_20191231.htm 10-K/A 809512
2 EX-4.4 ttoo-ex44_116.htm EX-4.4 25929
3 EX-31.3 ttoo-ex313_6.htm EX-31.3 17201
4 EX-31.4 ttoo-ex314_13.htm EX-31.4 20939
  Complete submission text file 0001564590-20-019519.txt   874570
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36571 | Film No.: 20828469
SIC: 3841 Surgical & Medical Instruments & Apparatus